Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study

被引:9
作者
Chidambaram, Swathikan [1 ]
Owen, Richard [2 ,3 ]
Sgromo, Bruno [2 ]
Chmura, Magdalena [2 ]
Kisiel, Aaron [4 ]
Evans, Richard [4 ]
Griffiths, Ewen A. [4 ]
Castoro, Carlo [5 ]
Gronnier, Caroline [6 ]
Maoawyes, Mometo Ali [7 ]
Gutschow, Christian A. [7 ]
Piessen, Guillaume [8 ]
Degisors, Sebastien [8 ]
Alvieri, Rita [9 ]
Feldman, Hope [10 ]
Capovilla, Giovanni [11 ]
Grimminger, Peter P. [11 ]
Han, Shiwei [12 ,13 ]
Low, Donald E. [12 ,13 ]
Moore, Jonathan [14 ]
Gossage, James [14 ]
Voeten, Dan [15 ]
Gisbertz, Suzanne S. [15 ]
Ruurda, Jelle [16 ]
van Hillegersberg, Richard [16 ]
D'Journo, Xavier B. [17 ]
Chmelo, Jakub [18 ]
Phillips, Alexander W. [18 ]
Rosati, Riccardo [19 ]
Hanna, George B. [1 ]
Maynard, Nick [2 ]
Hofstetter, Wayne [10 ]
Ferri, Lorenzo [20 ]
Berge Henegouwen, Mark I. [15 ]
Markar, Sheraz R. [2 ,21 ]
机构
[1] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Acad Surg Unit, London, England
[2] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Surg, Oxford, England
[3] Univ Oxford, Ludwig Inst Canc Res, Oxford, England
[4] Birmingham Univ Hosp NHS Fdn Trust, Queen Elizabeth Hosp, Dept Surg, Birmingham, England
[5] Humanitas Res Hosp, Gen Gastr & Esophagus Surg Unit, Rozzano, Italy
[6] CHU Bordeaux, Ctr Magellan, Digest Surg Dept, Esophageal & Endocrine Surg Unit, Bordeaux, France
[7] Univ Hosp Zurich, Comprehens Canc Ctr, Stomach & Oesophageal Tumor Ctr, Zurich, Switzerland
[8] Univ Hosp Claude Huriez, Dept Digest & Gen Surg, Cedex, Lille, France
[9] IOV IRCCS, Veneto Inst Oncol, Oncol Surg Unit, Padua, Italy
[10] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[11] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Surg, Mainz, Germany
[12] Virginia Mason Hosp, Dept Thorac Surg & Thorac Oncol, Seattle, WA USA
[13] Seattle Med Ctr, Seattle, WA USA
[14] Guys & St Thomas Hosp NHS Fdn Trust, Dept Surg, London, England
[15] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Netherlands
[16] Univ Med Ctr, Dept Upper Gastrointestinal Surg, Utrecht, Netherlands
[17] North Hosp, Dept Thorac Surg Dis Esophagus & Lung Transplantat, Chemin Bourrely, Marseille, France
[18] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Esophagogastr Unit, Newcastle Upon Tyne, England
[19] Osped San Raffaele, Dept GI Surg, Milan, Italy
[20] McGill Univ, Montreal Gen Hosp, Dept Surg & Oncol, Montreal, PQ, Canada
[21] Univ Oxford, Nuffield Dept Surg, Oxford, England
关键词
chemoradiotherapy; esophageal cancer; esophagectomy; salvage esophagectomy; PHASE-III TRIAL; RADIATION-THERAPY; SURGERY; CHEMORADIATION; RADIOTHERAPY; MORBIDITY; MORTALITY; SURVIVAL; OUTCOMES;
D O I
10.1097/SLA.0000000000006028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of delayed surgical intervention following chemoradiotherapy (CRT) on survival from esophageal cancer.Background: CRT is a core component of multimodality treatment for locally advanced esophageal cancer. The timing of surgery following CRT may influence the probability of performing an oncological resection and the associated operative morbidity.Methods: This was an international, multicenter, cohort study, including patients from 17 centers who received CRT followed by surgery between 2010 and 2020. In the main analysis, patients were divided into 4 groups based upon the interval between CRT and surgery (0-50, 51-100, 101-200, and >200 days) to assess the impact upon 90-day mortality and 5-year overall survival. Multivariable logistic and Cox regression provided hazard ratios (HRs) with 95% CIs adjusted for relevant patient, oncological, and pathologic confounding factors.Results: A total of 2867 patients who underwent esophagectomy after CRT were included. After adjustment for relevant confounders, prolonged interval following CRT was associated with an increased 90-day mortality compared with 0 to 50 days (reference): 51 to 100 days (HR=1.54, 95% CI: 1.04-2.29), 101 to 200 days (HR=2.14, 95% CI: 1.37-3.35), and >200 days (HR=3.06, 95% CI: 1.64-5.69). Similarly, a poorer 5-year overall survival was also observed with prolonged interval following CRT compared with 0 to 50 days (reference): 101 to 200 days (HR=1.41, 95% CI: 1.17-1.70), and >200 days (HR=1.64, 95% CI: 1.24-2.17).Conclusions: Prolonged interval following CRT before esophagectomy is associated with increased 90-day mortality and poorer long-term survival. Further investigation is needed to understand the mechanism that underpins these adverse outcomes observed with a prolonged interval to surgery.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [1] Frequency of surgical resection after starting neoadjuvant chemoradiotherapy in patients with esophageal cancer: A population-based cohort study
    Borggreve, Alicia S.
    van Rossum, Peter S. N.
    Mook, Stella
    Mohammad, Nadia Haj
    van Hillegersberg, Richard
    Ruurda, Jelle P.
    EJSO, 2019, 45 (10): : 1919 - 1925
  • [2] Impact of Neoadjuvant Chemoradiotherapy on Postoperative Outcomes After Esophageal Cancer Resection Results of a European Multicenter Study
    Gronnier, Caroline
    Trechot, Boris
    Duhamel, Alain
    Mabrut, Jean-Yves
    Bail, Jean-Pierre
    Carrere, Nicolas
    Lefevre, Jeremie H.
    Brigand, Cecile
    Vaillant, Jean-Christophe
    Adham, Mustapha
    Msika, Simon
    Demartines, Nicolas
    El Nakadi, Issam
    Piessen, Guillaume
    Meunier, Bernard
    Collet, Denis
    Mariette, Christophe
    ANNALS OF SURGERY, 2014, 260 (05) : 764 - 771
  • [3] Salvage Esophagectomy After Definitive Chemoradiotherapy for Thoracic Esophageal Cancer
    Miyata, Hiroshi
    Yamasaki, Makoto
    Takiguchi, Shuji
    Nakajima, Kiyokazu
    Fujiwara, Yoshiyuki
    Nishida, Toshiro
    Mori, Masaki
    Doki, Yuichiro
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (06) : 442 - 446
  • [4] Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer
    Jiang, W.
    Verma, V.
    Haque, W.
    Moreno, A. C.
    Koshy, M.
    Butler, E. B.
    Teh, B. S.
    DISEASES OF THE ESOPHAGUS, 2020, 33 (04)
  • [5] Timing of surgery after neoadjuvant chemoradiotherapy affects oncologic outcomes in patients with esophageal cancer
    Shang, Qi-Xin
    Yang, Yu-Shang
    Gu, Yi-Min
    Zeng, Xiao-Xi
    Zhang, Han-Lu
    Hu, Wei-Peng
    Wang, Wen-Ping
    Chen, Long-Qi
    Yuan, Yong
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (06) : 687 - 698
  • [6] Clinical Significance of Chemoradiotherapy and Surgical Resection for cT4 Esophageal Cancer
    Morita, Masaru
    Toh, Yasushi
    Saeki, Hiroshi
    Sugiyama, Masahiko
    Ohgaki, Kippei
    Maehara, Shin-Ichiro
    Minami, Kazuhito
    Ikeda, Yasuharu
    Sakaguchi, Yoshihisa
    Okamura, Takeshi
    Uehara, Satoru
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2012, 32 (08) : 3275 - 3282
  • [7] Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer: National Population-based Cohort Study
    Kamarajah, Sivesh K.
    Phillips, Alexander W.
    Hanna, George B.
    Low, Donald
    Markar, Sheraz R.
    ANNALS OF SURGERY, 2022, 275 (03) : 526 - 533
  • [8] Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma
    Levinsky, Nick C.
    Wima, Koffi
    Morris, Mackenzie C.
    Ahmad, Syed A.
    Shah, Shimul A.
    Starnes, Sandra L.
    Van Haren, Robert M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (06) : 2555 - 2566
  • [9] Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
    van Hagen, P.
    Hulshof, M. C. C. M.
    van Lanschot, J. J. B.
    Steyerberg, E. W.
    Henegouwen, M. I. van Berge
    Wijnhoven, B. P. L.
    Richel, D. J.
    Nieuwenhuijzen, G. A. P.
    Hospers, G. A. P.
    Bonenkamp, J. J.
    Cuesta, M. A.
    Blaisse, R. J. B.
    Busch, O. R. C.
    ten Kate, F. J. W.
    Creemers, G. -J.
    Punt, C. J. A.
    Plukker, J. T. M.
    Verheul, H. M. W.
    Bilgen, E. J. Spillenaar
    van Dekken, H.
    van der Sangen, M. J. C.
    Rozema, T.
    Biermann, K.
    Beukema, J. C.
    Piet, A. H. M.
    van Rij, C. M.
    Reinders, J. G.
    Tilanus, H. W.
    van der Gaast, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (22) : 2074 - 2084
  • [10] Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
    Markar, Sheraz
    Gronnier, Caroline
    Duhamel, Alain
    Pasquer, Arnaud
    Thereaux, Jeremie
    du Rieu, Mael Chalret
    Lefevre, Jeremie H.
    Turner, Kathleen
    Luc, Guillaume
    Mariette, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (33) : 3866 - +